Recombinant Human BTC, LEVLFQ tagged

• Cat.No.: BTC-268H
• Product Overview: Recombinant Human BTC (P35070) (Met1-Tyr111), fused with six amino acids (LEVLFQ) at the C-terminus, was produced in Human Cells.

Specification

• Species: Human
• Source: Human Cells
• Tag: His
• Protein Length: 1-111 a.a.
• Predicted N Terminal: Asp 32
• Form: Lyophilized from sterile PBS, pH 7.4.Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization.
• Molecular Mass: The recombinant human BTC comprises 87 amino acids and has a predicted molecular mass of 9.8 kDa. The apparent molecular mass of the protein is approximately 24 kDa in SDS-PAGE under reducing conditions.
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >90 % as determined by SDS-PAGE
• Stability: Samples are stable for up to twelve months from date of receipt at -70oC.
• Storage: Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution. Centrifuge the vial at 4℃ before opening to recover the entire contents.

Gene Information

• Gene Name: BTC betacellulin [ Homo sapiens ]
• Official Symbol: BTC
• Gene ID: 685
• mRNA Refseq: NM_001729
• Protein Refseq: NP_001720
• MIM: 600345
• UniProt ID: P35070
• Chromosome Location: 4q13-q21